19411100

Source:http://linkedlifedata.com/resource/pubmed/id/19411100

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0086511, umls-concept:C0206460, umls-concept:C1739768
pubmed:issue	9676
pubmed:dateCreated	2009-5-18
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00362232
pubmed:abstractText	Prophylaxis for venous thromboembolism is recommended for at least 10 days after total knee arthroplasty; oral regimens could enable shorter hospital stays. We aimed to test the efficacy and safety of oral rivaroxaban for the prevention of venous thromboembolism after total knee arthroplasty.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19411100-19411101, http://linkedlifedata.com/resource/pubmed/commentcorrection/19411100-19716952, http://linkedlifedata.com/resource/pubmed/commentcorrection/19411100-19716953, http://linkedlifedata.com/resource/pubmed/commentcorrection/19411100-19716954, http://linkedlifedata.com/resource/pubmed/commentcorrection/19411100-19716955
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985213R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Enoxaparin, http://linkedlifedata.com/resource/pubmed/chemical/Morpholines, http://linkedlifedata.com/resource/pubmed/chemical/Thiophenes, http://linkedlifedata.com/resource/pubmed/chemical/rivaroxaban
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1474-547X
pubmed:author	pubmed-author:BandelTiemo JTJ, pubmed-author:BauerKenneth AKA, pubmed-author:BensonAliceA, pubmed-author:BerkowitzScott DSD, pubmed-author:CushnerFred DFD, pubmed-author:DavidsonBruce LBL, pubmed-author:FisherWilliam DWD, pubmed-author:GentMichaelM, pubmed-author:KwongLouis MLM, pubmed-author:LassenMichael RMR, pubmed-author:LotkePaul APA, pubmed-author:MisselwitzFrankF, pubmed-author:RECORD4 Investigators, pubmed-author:TurpieAlexander G GAG
pubmed:issnType	Electronic
pubmed:day	16
pubmed:volume	373
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1673-80
pubmed:dateRevised	2009-8-31
pubmed:meshHeading	pubmed-meshheading:19411100-Administration, Oral, pubmed-meshheading:19411100-Aged, pubmed-meshheading:19411100-Analysis of Variance, pubmed-meshheading:19411100-Anticoagulants, pubmed-meshheading:19411100-Arthroplasty, Replacement, Knee, pubmed-meshheading:19411100-Double-Blind Method, pubmed-meshheading:19411100-Enoxaparin, pubmed-meshheading:19411100-Female, pubmed-meshheading:19411100-Follow-Up Studies, pubmed-meshheading:19411100-Hemorrhage, pubmed-meshheading:19411100-Humans, pubmed-meshheading:19411100-Incidence, pubmed-meshheading:19411100-Male, pubmed-meshheading:19411100-Middle Aged, pubmed-meshheading:19411100-Morpholines, pubmed-meshheading:19411100-Phlebography, pubmed-meshheading:19411100-Risk Reduction Behavior, pubmed-meshheading:19411100-Sensitivity and Specificity, pubmed-meshheading:19411100-Thiophenes, pubmed-meshheading:19411100-Treatment Outcome, pubmed-meshheading:19411100-Venous Thrombosis
pubmed:year	2009
pubmed:articleTitle	Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.
pubmed:affiliation	McMaster University, Hamilton, Ontario L8L 2X2, Canada. turpiea@mcmaster.ca
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III